Literature DB >> 3180894

International trends in asthma mortality: 1970 to 1985.

R Jackson1, M R Sears, R Beaglehole, H H Rea.   

Abstract

Recent international trends in asthma mortality among people aged five to 34 years were examined as a follow-up to an epidemic of asthma deaths in the late 1970s which appeared to be confined to New Zealand. Mortality rates were compared in 14 countries with suitable statistics; Australia, Canada, England and Wales, Finland, France, Japan, Israel, the Netherlands, New Zealand, Singapore, Sweden, Switzerland, the United States, and West Germany, for the period 1970 to 1984/5. In New Zealand, asthma mortality in this age group more than trebled from 1.3 per 100,000 in 1974 to 4.2 per 100,000 in 1979 and since then has declined substantially to 1.85 per 100,000 in 1985. Asthma death rates vary more than six-fold among the other countries examined, and although the New Zealand experience has not been seen to the same degree elsewhere, a gradual increase in reported asthma mortality has occurred since the mid to late 1970s in the majority of countries studied. The increase and subsequent decline in asthma mortality in New Zealand could not be explained by changes in diagnostic fashions or in the International Classification of Disease coding rules. Similarly, the US data do not suggest there is diagnostic transfer among diseases of airway obstruction. However, part of the differences in asthma mortality among the countries examined and the recent increases in asthma death rates, could be due to changing diagnostic fashions rather than true differences in mortality. International studies on the validity of asthma death statistics and on asthma prevalence are required to clarify these issues.

Entities:  

Mesh:

Year:  1988        PMID: 3180894     DOI: 10.1378/chest.94.5.914

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  39 in total

1.  Asthma and exercise: a suitable case for rehabilitation?

Authors:  C J Clark
Journal:  Thorax       Date:  1992-10       Impact factor: 9.139

Review 2.  The economic costs of asthma: a review and conceptual model.

Authors:  K B Weiss; S D Sullivan
Journal:  Pharmacoeconomics       Date:  1993-07       Impact factor: 4.981

3.  Asthma and regular beta agonist treatment.

Authors:  B Richter
Journal:  BMJ       Date:  1991-09-14

4.  Screening and surveillance of school aged children.

Authors:  J W Tuke
Journal:  BMJ       Date:  1990-05-05

5.  Growing number of asthma cases, deaths baffles physicians.

Authors: 
Journal:  CMAJ       Date:  1991-09-01       Impact factor: 8.262

Review 6.  Beta-agonists and asthma mortality. What have we learned, what questions remain?

Authors:  A J Woolcock
Journal:  Drugs       Date:  1990-11       Impact factor: 9.546

7.  Mortality of adults with asthma: a prospective cohort study.

Authors:  E Huovinen; J Kaprio; E Vesterinen; M Koskenvuo
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

8.  Demographic characteristics of patients with severe life threatening asthma: comparison with asthma deaths.

Authors:  G N Richards; J Kolbe; J Fenwick; H H Rea
Journal:  Thorax       Date:  1993-11       Impact factor: 9.139

9.  Regular inhaled beta agonist in asthma: effects on exacerbations and lung function.

Authors:  D R Taylor; M R Sears; G P Herbison; E M Flannery; C G Print; D C Lake; D M Yates; M K Lucas; Q Li
Journal:  Thorax       Date:  1993-02       Impact factor: 9.139

10.  Correlates of asthma morbidity in primary care.

Authors:  K P Jones; D J Bain; M Middleton; M A Mullee
Journal:  BMJ       Date:  1992-02-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.